These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36416551)

  • 1. CRISPR-Cas9 Editing Induces Loss of Heterozygosity in the Pathogenic Yeast Candida parapsilosis.
    Lombardi L; Bergin SA; Ryan A; Zuniga-Soto E; Butler G
    mSphere; 2022 Dec; 7(6):e0039322. PubMed ID: 36416551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing gene function in
    Ramírez-Zavala B; Hoffmann A; Krüger I; Schwanfelder S; Barker KS; Rogers PD; Morschhäuser J
    mSphere; 2024 Jul; 9(7):e0038824. PubMed ID: 38940507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple
    Lombardi L; Oliveira-Pacheco J; Butler G
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30867327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.
    Lombardi L; Turner SA; Zhao F; Butler G
    Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific genome editing using CRISPR-Cas9 is associated with loss of heterozygosity in diploid yeast.
    Gorter de Vries AR; Couwenberg LGF; van den Broek M; de la Torre Cortés P; Ter Horst J; Pronk JT; Daran JG
    Nucleic Acids Res; 2019 Feb; 47(3):1362-1372. PubMed ID: 30517747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of CRISPR-Cas9 To Target Homologous Recombination Limits Transformation-Induced Genomic Changes in Candida albicans.
    Marton T; Maufrais C; d'Enfert C; Legrand M
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Recessive Lethal Alleles in the Diploid Genome of a Candida albicans Laboratory Strain Unveils a Potential Role of Repetitive Sequences in Buffering Their Deleterious Impact.
    Marton T; Feri A; Commere PH; Maufrais C; d'Enfert C; Legrand M
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells.
    Boutin J; Rosier J; Cappellen D; Prat F; Toutain J; Pennamen P; Bouron J; Rooryck C; Merlio JP; Lamrissi-Garcia I; Cullot G; Amintas S; Guyonnet-Duperat V; Ged C; Blouin JM; Richard E; Dabernat S; Moreau-Gaudry F; Bedel A
    Nat Commun; 2021 Aug; 12(1):4922. PubMed ID: 34389729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Repair Mechanisms following an Induced Double-Strand Break Uncovers Recessive Deleterious Alleles in the Candida albicans Diploid Genome.
    Feri A; Loll-Krippleber R; Commere PH; Maufrais C; Sertour N; Schwartz K; Sherlock G; Bougnoux ME; d'Enfert C; Legrand M
    mBio; 2016 Oct; 7(5):. PubMed ID: 27729506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CRISPR/Cas9-based strategy to simultaneously inactivate the entire
    Zoppo M; Luca MD; Villarreal SN; Poma N; Barrasa MI; Bottai D; Vyas VK; Tavanti A
    Future Microbiol; 2019 Nov; 14():1383-1396. PubMed ID: 31659913
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmid-Based CRISPR-Cas9 Editing in Multiple Candida Species.
    Lombardi L; Butler G
    Methods Mol Biol; 2022; 2542():13-40. PubMed ID: 36008654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.
    Alanis-Lobato G; Zohren J; McCarthy A; Fogarty NME; Kubikova N; Hardman E; Greco M; Wells D; Turner JMA; Niakan KK
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
    Morio F; Lombardi L; Binder U; Loge C; Robert E; Graessle D; Bodin M; Lass-Flörl C; Butler G; Le Pape P
    J Antimicrob Chemother; 2019 Aug; 74(8):2230-2238. PubMed ID: 31106355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans.
    Evans BA; Pickerill ES; Vyas VK; Bernstein DA
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPR/Cas9 method to generate heterozygous alleles in Saccharomyces cerevisiae.
    EauClaire SF; Webb CJ
    Yeast; 2019 Oct; 36(10):607-615. PubMed ID: 31301239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Genome of the Human Pathogen
    Wang JM; Bennett RJ; Anderson MZ
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpALS4770 and CpALS4780 contribution to the virulence of Candida parapsilosis.
    Zoppo M; Di Luca M; Franco M; Rizzato C; Lupetti A; Stringaro A; De Bernardis F; Schaudinn C; Barrasa MI; Bottai D; Vyas VK; Tavanti A
    Microbiol Res; 2020 Jan; 231():126351. PubMed ID: 31707298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 engineering in the hybrid yeast Zygosaccharomyces parabailii can lead to loss of heterozygosity in target chromosomes.
    Jayaprakash P; Barroso L; Vajente M; Maestroni L; Louis EJ; Morrissey JP; Branduardi P
    FEMS Yeast Res; 2023 Jan; 23():. PubMed ID: 37458780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
    Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
    Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crispr/Cas9-mediated cleavages facilitate homologous recombination during genetic engineering of a large chromosomal region.
    Zhang F; Cheng D; Wang S; Zhu J
    Biotechnol Bioeng; 2020 Sep; 117(9):2816-2826. PubMed ID: 32449788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.